WASHINGTON, Dec. 11 (HSMN NewsFeed) — The following is GlaxoSmithKline’s (NYSE: GSK ) statement regarding recommendations of a combined Advisory Committee to the FDA on the use of asthma medicines containing long-acting beta agonists, including GSK’s Se…
Biopharmaceuticals
GlaxoSmithKline, Serevent, salmeterol, Advair, fluticasone, asthma

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists”
Leave a Comment